Dr. Reddys Laboratories informs about press release

17 Sep 2020 Evaluate

Dr. Reddys Laboratories has informed that it has enclosed a Press Release on 17th September 2020 titled ‘Dr. Reddy’s announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store-brand equivalent of Pataday®, the Eye Allergy Drop in the U.S. Market’.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Lab Share Price

1208.55 -15.75 (-1.29%)
29-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.55
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2122.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×